Editorial Open Access
Volume 2 | Issue 3 | DOI: https://doi.org/10.33696/cancerimmunol.2.016
Cellular Response to Stress: At the Crossroads between Immunosenescence and Cancer
Christian R. Gomez1,2,3,*
- 1Department of Pathology, University of Mississippi Center for Clinical and Translational Science, University of Mississippi Medical Center, Jackson, MS 39216, USA
- 2Department of Radiation Oncology, University of Mississippi Center for Clinical and Translational Science, University of Mississippi Medical Center, Jackson, MS 39216, USA
- 3Translational and Clinical Research Unit, University of Mississippi Center for Clinical and Translational Science, University of Mississippi Medical Center, Jackson, MS 39216, USA
Corresponding Author
Christian R. Gomez, crgomez@umc.edu
Received Date: June 01, 2020
Accepted Date: June 01, 2020
Gomez CR. Cellular Response to Stress: At the Crossroads between Immunosenescence and Cancer. J Cancer Immunol. 2(3): 60-61.
Copyright: © 2020 Gomez CR. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Keywords
Aging, Cancer, Stress, Immunosenescence, Innate immunity
Recommended Articles
Escherichia coli Stress, Multi-cellularity, and the Generation of the Quorum Sensing Peptide EDF
Bacterial communication via quorum sensing (QS) molecules, as well as toxin-antitoxin (TA) gene modules located on bacterial chromosomes are well-studied mechanisms. Escherichia coli mazEF is a stress-induced TA system mediating cell death requiring a QS extracellular death factor (EDF), the pentapeptide NNWNN. MazF is an endoribonuclease specific for ACA sites. During adverse conditions, the activated MazF generates a stress induced translation machinery, composed of MazF-processed mRNAs and selective ribosomes that specifically translate these processed mRNAs.
Prevalence of Symptom Clusters in Cancer Patients at First Presentation in Palliative Care Clinic as per Different Disease Groups
Cancer has its own disease burden and patients usually suffer from symptom clusters when they are referred for palliative treatment. Identification of symptom cluster trajectories will help clinician to take into account measures that can optimize quality of life of palliative patients. Therefore the aim of this paper is to determine the overall prevalence of symptoms and symptoms clusters in different disease groups according to etiology at the time of first visit to Palliative care clinic by using HIS Palliative First Assessment note indicating Edmonton symptom scale.
Chimeric Antigen Receptor CAR NK Cells Emerging Immunotherapy for the Treatment of Cancer
Although NK cells are recognized as effector lymphocytes of the innate immune system, they also regulate the adaptive immune response by releasing inflammatory cytokines and developing immunological memory. Unlike other lymphocytes such as T or B cells, NK cells do not express rearrangeable, antigen-specific receptors.
Emerging Role of TRPML1 Mucolipin Endolysosomal Channel in Cancer
The transient receptor potential mucolipin 1 (TRPML1) is an endolysosomal channel belonging to the TRP family. Clinically, mutations of TRPML1 have been responsible for a severe lysosomal storage disorder called mucolipidosis type IV.
Manipulating Oxidative Stress Following Ionizing Radiation
It is now well accepted that the ionizing radiation-generated reactive oxygen species (ROS), that constitute ~2/3 of the effects of external beam radiation, do not only produce direct tumor cell death, but also affect the surrounding microenvironment. Moreover, this indirect effect of radiation may result in systemic effects, specifically the initiation of an inflammatory response.